![logo](/logos/ANIP.webp)
ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
60.51 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | ANI Pharmaceuticals, Inc. |
Symbool | ANIP |
Munteenheid | USD |
Prijs | 60.51 |
Beurswaarde | 1,272,531,351 |
Dividendpercentage | 0% |
52-weken bereik | 48.2 - 70.81 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Nikhil Lalwani |
Website | https://www.anipharmaceuticals.com |
An error occurred while fetching data.
Over ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)